questionsmedicales.fr
Régions géographiques
Océanie
Australasie
Australasie : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Australasie : Questions médicales les plus fréquentes",
"headline": "Australasie : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Australasie : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-22",
"dateModified": "2025-04-17",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Australasie"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Océanie",
"url": "https://questionsmedicales.fr/mesh/D044349",
"about": {
"@type": "MedicalCondition",
"name": "Océanie",
"code": {
"@type": "MedicalCode",
"code": "D044349",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.678"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Australie",
"alternateName": "Australia",
"url": "https://questionsmedicales.fr/mesh/D001315",
"about": {
"@type": "MedicalCondition",
"name": "Australie",
"code": {
"@type": "MedicalCode",
"code": "D001315",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.678.100.373"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Territoire de la capitale australienne",
"alternateName": "Australian Capital Territory",
"url": "https://questionsmedicales.fr/mesh/D020958",
"about": {
"@type": "MedicalCondition",
"name": "Territoire de la capitale australienne",
"code": {
"@type": "MedicalCode",
"code": "D020958",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.678.100.373.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Nouvelle-Galles du Sud",
"alternateName": "New South Wales",
"url": "https://questionsmedicales.fr/mesh/D009517",
"about": {
"@type": "MedicalCondition",
"name": "Nouvelle-Galles du Sud",
"code": {
"@type": "MedicalCode",
"code": "D009517",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.678.100.373.750"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Territoire du Nord",
"alternateName": "Northern Territory",
"url": "https://questionsmedicales.fr/mesh/D015876",
"about": {
"@type": "MedicalCondition",
"name": "Territoire du Nord",
"code": {
"@type": "MedicalCode",
"code": "D015876",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.678.100.373.875"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Queensland",
"alternateName": "Queensland",
"url": "https://questionsmedicales.fr/mesh/D011793",
"about": {
"@type": "MedicalCondition",
"name": "Queensland",
"code": {
"@type": "MedicalCode",
"code": "D011793",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.678.100.373.937"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Australie-Méridionale",
"alternateName": "South Australia",
"url": "https://questionsmedicales.fr/mesh/D013021",
"about": {
"@type": "MedicalCondition",
"name": "Australie-Méridionale",
"code": {
"@type": "MedicalCode",
"code": "D013021",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.678.100.373.968"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Tasmanie",
"alternateName": "Tasmania",
"url": "https://questionsmedicales.fr/mesh/D013648",
"about": {
"@type": "MedicalCondition",
"name": "Tasmanie",
"code": {
"@type": "MedicalCode",
"code": "D013648",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.678.100.373.984"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Victoria",
"alternateName": "Victoria",
"url": "https://questionsmedicales.fr/mesh/D014739",
"about": {
"@type": "MedicalCondition",
"name": "Victoria",
"code": {
"@type": "MedicalCode",
"code": "D014739",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.678.100.373.992"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Australie occidentale",
"alternateName": "Western Australia",
"url": "https://questionsmedicales.fr/mesh/D014904",
"about": {
"@type": "MedicalCondition",
"name": "Australie occidentale",
"code": {
"@type": "MedicalCode",
"code": "D014904",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.678.100.373.996"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Nouvelle-Zélande",
"alternateName": "New Zealand",
"url": "https://questionsmedicales.fr/mesh/D009520",
"about": {
"@type": "MedicalCondition",
"name": "Nouvelle-Zélande",
"code": {
"@type": "MedicalCode",
"code": "D009520",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.678.100.747"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Iles du Pacifique",
"alternateName": "Pacific Islands",
"url": "https://questionsmedicales.fr/mesh/D010139",
"about": {
"@type": "MedicalCondition",
"name": "Iles du Pacifique",
"code": {
"@type": "MedicalCode",
"code": "D010139",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.678.100.873"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Australasie",
"alternateName": "Australasia",
"code": {
"@type": "MedicalCode",
"code": "D044362",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Ainsley J Newson",
"url": "https://questionsmedicales.fr/author/Ainsley%20J%20Newson",
"affiliation": {
"@type": "Organization",
"name": "Faculty of Medicine and Health, Sydney School of Public Health, Sydney Health Ethics, The University of Sydney, Sydney, NSW, Australia."
}
},
{
"@type": "Person",
"name": "Thomas Beaney",
"url": "https://questionsmedicales.fr/author/Thomas%20Beaney",
"affiliation": {
"@type": "Organization",
"name": "Imperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London, UK."
}
},
{
"@type": "Person",
"name": "Xin Xia",
"url": "https://questionsmedicales.fr/author/Xin%20Xia",
"affiliation": {
"@type": "Organization",
"name": "Imperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London, UK."
}
},
{
"@type": "Person",
"name": "Neil R Poulter",
"url": "https://questionsmedicales.fr/author/Neil%20R%20Poulter",
"affiliation": {
"@type": "Organization",
"name": "Imperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London, UK."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Presence of HPV in prostate tissue from patients submitted to prostate biopsy.",
"datePublished": "2023-01-13",
"url": "https://questionsmedicales.fr/article/36651430",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1590/acb371205"
}
},
{
"@type": "ScholarlyArticle",
"name": "Total Prostate Specific Antigen in Prostate Cancer Screening in Hyperglycemic Individuals.",
"datePublished": "2022-09-24",
"url": "https://questionsmedicales.fr/article/36253300",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.clgc.2022.09.007"
}
},
{
"@type": "ScholarlyArticle",
"name": "The mendelian randomized study revealed the association of prostatitis with prostate cancer risk.",
"datePublished": "2024-10-20",
"url": "https://questionsmedicales.fr/article/39428439",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-024-76355-4"
}
},
{
"@type": "ScholarlyArticle",
"name": "Automatic detection of prostate cancer grades and chronic prostatitis in biparametric MRI.",
"datePublished": "2023-05-26",
"url": "https://questionsmedicales.fr/article/37271051",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.cmpb.2023.107624"
}
},
{
"@type": "ScholarlyArticle",
"name": "Is systematic prostate biopsy an overkill in metastatic prostate carcinoma ? A prospective validation.",
"datePublished": "2023-03-14",
"url": "https://questionsmedicales.fr/article/36917412",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s11255-023-03531-2"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Régions géographiques",
"item": "https://questionsmedicales.fr/mesh/D005842"
},
{
"@type": "ListItem",
"position": 3,
"name": "Océanie",
"item": "https://questionsmedicales.fr/mesh/D044349"
},
{
"@type": "ListItem",
"position": 4,
"name": "Australasie",
"item": "https://questionsmedicales.fr/mesh/D044362"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Australasie - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Australasie",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-17",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Australasie",
"description": "Comment diagnostiquer une maladie tropicale en Australasie ?\nQuels tests sont utilisés pour le paludisme en Australasie ?\nComment identifier une infection par le virus Zika ?\nQuels sont les signes d'une infection à leptospirose ?\nComment diagnostiquer une maladie de Lyme en Australasie ?",
"url": "https://questionsmedicales.fr/mesh/D044362?mesh_terms=Prostatic+Neoplasms&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Australasie",
"description": "Quels sont les symptômes du chikungunya ?\nComment se manifeste la dengue ?\nQuels signes indiquent une infection par le virus de l'herpès ?\nQuels symptômes d'une intoxication alimentaire ?\nComment reconnaître une infection respiratoire ?",
"url": "https://questionsmedicales.fr/mesh/D044362?mesh_terms=Prostatic+Neoplasms&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Australasie",
"description": "Comment prévenir la dengue en Australasie ?\nQuelles mesures pour éviter le chikungunya ?\nComment se protéger contre le virus Zika ?\nQuelles sont les recommandations pour la leptospirose ?\nComment prévenir les infections respiratoires ?",
"url": "https://questionsmedicales.fr/mesh/D044362?mesh_terms=Prostatic+Neoplasms&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Australasie",
"description": "Quels traitements pour la dengue ?\nComment traiter une infection par le virus Zika ?\nQuels médicaments pour le chikungunya ?\nComment traiter une infection à leptospirose ?\nQuels sont les traitements pour la maladie de Lyme ?",
"url": "https://questionsmedicales.fr/mesh/D044362?mesh_terms=Prostatic+Neoplasms&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Australasie",
"description": "Quelles complications peuvent survenir avec la dengue ?\nQuels risques associés au chikungunya ?\nQuelles complications de l'infection par le virus Zika ?\nQuelles complications de la leptospirose ?\nQuels risques de la maladie de Lyme non traitée ?",
"url": "https://questionsmedicales.fr/mesh/D044362?mesh_terms=Prostatic+Neoplasms&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Australasie",
"description": "Quels sont les facteurs de risque pour la dengue ?\nQui est à risque pour le chikungunya ?\nQuels facteurs augmentent le risque de virus Zika ?\nQuels sont les risques associés à la leptospirose ?\nQui est à risque pour la maladie de Lyme ?",
"url": "https://questionsmedicales.fr/mesh/D044362?mesh_terms=Prostatic+Neoplasms&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une maladie tropicale en Australasie ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un diagnostic repose sur l'historique médical, les symptômes et des tests de laboratoire."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le paludisme en Australasie ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests de diagnostic incluent les frottis sanguins et les tests de dépistage rapide."
}
},
{
"@type": "Question",
"name": "Comment identifier une infection par le virus Zika ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'infection est confirmée par des tests sanguins spécifiques et l'historique de voyage."
}
},
{
"@type": "Question",
"name": "Quels sont les signes d'une infection à leptospirose ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fièvre, douleurs musculaires et éruption cutanée, nécessitant des tests."
}
},
{
"@type": "Question",
"name": "Comment diagnostiquer une maladie de Lyme en Australasie ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'exposition aux tiques et des tests sérologiques spécifiques."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes du chikungunya ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fièvre, douleurs articulaires et éruptions cutanées."
}
},
{
"@type": "Question",
"name": "Comment se manifeste la dengue ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "La dengue se manifeste par une forte fièvre, des douleurs corporelles et des éruptions cutanées."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une infection par le virus de l'herpès ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent des lésions cutanées, des démangeaisons et des douleurs localisées."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'une intoxication alimentaire ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent nausées, vomissements, diarrhée et douleurs abdominales."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une infection respiratoire ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent toux, fièvre, essoufflement et douleurs thoraciques."
}
},
{
"@type": "Question",
"name": "Comment prévenir la dengue en Australasie ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éliminer les eaux stagnantes et utiliser des répulsifs contre les moustiques."
}
},
{
"@type": "Question",
"name": "Quelles mesures pour éviter le chikungunya ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des moustiquaires et des répulsifs, et éviter les zones infestées."
}
},
{
"@type": "Question",
"name": "Comment se protéger contre le virus Zika ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les piqûres de moustiques et utiliser des préservatifs lors de rapports sexuels."
}
},
{
"@type": "Question",
"name": "Quelles sont les recommandations pour la leptospirose ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter le contact avec des eaux potentiellement contaminées et porter des vêtements de protection."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections respiratoires ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Se laver les mains régulièrement et éviter les contacts avec des personnes malades."
}
},
{
"@type": "Question",
"name": "Quels traitements pour la dengue ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement est symptomatique, avec des analgésiques et une hydratation adéquate."
}
},
{
"@type": "Question",
"name": "Comment traiter une infection par le virus Zika ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de traitement spécifique ; le repos et l'hydratation sont recommandés."
}
},
{
"@type": "Question",
"name": "Quels médicaments pour le chikungunya ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les anti-inflammatoires et les analgésiques sont utilisés pour soulager les symptômes."
}
},
{
"@type": "Question",
"name": "Comment traiter une infection à leptospirose ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement comprend des antibiotiques et un suivi médical pour éviter les complications."
}
},
{
"@type": "Question",
"name": "Quels sont les traitements pour la maladie de Lyme ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antibiotiques sont le traitement principal, surtout s'ils sont administrés tôt."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec la dengue ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la dengue sévère, pouvant entraîner des hémorragies et un choc."
}
},
{
"@type": "Question",
"name": "Quels risques associés au chikungunya ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des douleurs articulaires chroniques peuvent persister longtemps après l'infection."
}
},
{
"@type": "Question",
"name": "Quelles complications de l'infection par le virus Zika ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le virus peut causer des malformations congénitales si contracté pendant la grossesse."
}
},
{
"@type": "Question",
"name": "Quelles complications de la leptospirose ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des lésions rénales, hépatiques et des hémorragies pulmonaires."
}
},
{
"@type": "Question",
"name": "Quels risques de la maladie de Lyme non traitée ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent inclure des problèmes neurologiques et des douleurs articulaires chroniques."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour la dengue ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent vivre dans des zones tropicales et avoir des antécédents d'infection."
}
},
{
"@type": "Question",
"name": "Qui est à risque pour le chikungunya ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes âgées et celles avec des maladies chroniques sont plus vulnérables."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de virus Zika ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Voyager dans des zones endommagées par le virus et être enceinte augmentent le risque."
}
},
{
"@type": "Question",
"name": "Quels sont les risques associés à la leptospirose ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes travaillant en milieu rural ou en contact avec des eaux contaminées sont à risque."
}
},
{
"@type": "Question",
"name": "Qui est à risque pour la maladie de Lyme ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes vivant dans des zones boisées ou ayant des activités de plein air sont à risque."
}
}
]
}
]
}
Prostate cancer (PCa) is the second most frequent cancer among men in the Western population. Infections, such as the one caused by the human papillomavirus (HPV), have been shown to promote inflammat...
Prostate tissue fragments were collected by prostate biopsy and subjected to polymerase chain reaction with primers for the HPV L1 gene to identify the presence of the virus....
Among 162 patients, 10 (6.2%) had HPV and in 152 (93.8%) HPV was not identified in prostate biopsies. HPV was detected in 7/95 (7.4%) of patients with PCa, in 2/55 (3.6%) of patients without PCa, and ...
There were no significant levels of HPV L1 protein in prostate tissue. The findings suggest the absence of HPV oncogenic activity in the prostate tissue of patients with PCa....
In this study, it was aimed to investigate the reliability of total prostate-specific antigen (t-PSA) in prostate cancer screening in hyperglycemic (≥126 mg/dL) individuals....
This research was planned as a cross-sectional retrospective study. Three hundred eleven cases which underwent biopsy with the suspicion of prostate cancer in the hospital were included in the study. ...
It was determined that the t-PSA measurement was higher in the patient group with cancer (P < .001). It was determined that the median t-PSA levels of the intermediate and high cancer groups were high...
As a contribution to literature, we found that the t-PSA test lost its sensitivity in cases with plasma glucose levels above normal. Loss of sensitivity may result in underdiagnosis in prostate cancer...
In recent observational studies, a potential link between prostatitis and prostate cancer (PCa) has been hinted at, yet the causality remains ambiguous. In our endeavor to scrutinize the conceivable c...
With emerging evidence to improve prostate cancer (PCa) screening, multiparametric magnetic prostate imaging is becoming an essential noninvasive component of the diagnostic routine. Computer-aided di...
We collected 1647 fine-grained biopsy-confirmed findings, including Gleason scores and prostatitis, to form a training dataset. In our experimental framework for lesion detection, all models utilized ...
An optimal model configuration with fine class granularity (prostatitis included) and OHE has scored the lesion-wise partial Free-Response Receiver Operating Characteristic (FROC) area under the curve...
This paper examines several configurations for model training in the biparametric MRI setup and proposes optimal value ranges. It also shows that the fine-grained class configuration, including prosta...
To assess the efficacy of 2-core prostate biopsy in advanced prostate cancer patients. This included a retrospective analysis of 12-core prostate biopsies and a prospective validation that a reduced n...
The first phase analyzed retrospective data from 12-core prostate biopsies between January 2013 and 2018. In the second phase, from January 2018 to January 2022, in a prospective setting, patients wit...
In the retrospective analysis, the number of positive cores in metastatic disease was 12 in 93 (73.8%), 11 in 14 (11.1%), and 10 in 7 (5.6%) patients. Using probability analysis, 94% of patients with ...
A 2-core biopsy is adequate in almost all patients with metastatic prostate cancer with PSA > 75, and this avoids excess complications and morbidity associated with a systematic 12-core prostate biops...
Financial toxicity (FT) is a growing concern among cancer survivors that adversely affects the quality of life and survival. Individuals diagnosed with aggressive cancers are often at a greater risk o...
PCa patients enrolled in the North Carolina-Louisiana Prostate Cancer Project (PCaP) were recontacted for long-term follow-up. The prevalence of FT in the PCaP cohort was estimated. FT was estimated u...
More than one-third of PCa patients reported experiencing FT. PCa aggressiveness was significantly independently associated with high FT; high aggressive PCa at diagnosis had more than twice the risk ...
Aggressive PCa was associated with high FT. Future studies should collect more information about the characteristics of men with high FT and identify additional risk factors of FT....
Prostate-specific membrane antigen (PSMA) hybrid imaging is a promising new technique gaining importance in the field of prostate cancer (PCa) diagnosis and treatment planning. By combining PSMA radio...
Cribriform (CBFM) pattern on prostate biopsy has been implicated as a predictor for high-risk features, potentially leading to adverse outcomes after definitive treatment. This study aims to investiga...
Patients who underwent multiparametric magnetic resonance imaging (mpMRI), combined 12-core transrectal ultrasound (TRUS) guided systematic (SB) and MRI/US fusion-guided biopsy were retrospectively qu...
Between 2015 and 2022, a total of 131 consecutive patients with CBFM pattern on prostate biopsy and pre-biopsy mpMRI were included. Clinical feature analysis included 1572 systematic biopsy cores (114...
The extent of disease for CBFM-containing tumors is difficult to capture on mpMRI. When comparing MRI lesions of similar dimensions and PIRADS scores, CBFM-containing tumors appear to have larger canc...
Purpose: Determine the time-dependent magnitude of intrafraction prostate displacement and a cutoff for the tracking decision. Methods: Nine patients with localized prostate cancer were treated with u...
Apart from other risk factors, chronic inflammation is also associated with the onset of Prostate Cancer (PCa), wherein pathogen infection and tissue microbiome dysbiosis are known to play a major rol...